April 12, 2026 Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia
April 12, 2026 J&T Express Q1 Parcel Volume Rises 26.2%, with Southeast Asia Growth Nearing 80% and Other Markets Doubling
April 12, 2026 Rosen Law Firm Encourages 3 E Network Technology Group Ltd. Investors to Inquire About Securities Class Action Investigation – MASK
April 12, 2026 JILL Investors Have Opportunity to Join J.Jill, Inc. Fraud Investigation with the Schall Law Firm
